Acadia Pharmaceuticals | ACAD - Índice Preço/Lucro





Pe Alterar Data
Acadia Pharmaceuticals 9.52 1.81 2026-09
ALKERMES 262.4 126.59 2026-09
Alnylam Pharmaceuticals 13.17 62.47 2026-09
Biogen 29.15 5.92 2026-09
BioMarin Pharmaceutical 53.62 32.55 2026-09
Bristol-Myers Squibb 10.44 5.7 2026-09
Cara Therapeutics 0.49 27.28 2026-03
Corcept Therapeutics 86.2 102.04 2026-09
Eisai 30.24 3.68 2026-09
Eli Lilly 64.5 31.61 2026-09
Incyte 54.54 40.08 2026-09
J&J 25.86 3.57 2026-09
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 83.17 61.07 2026-09
Pfizer 15.2 3.72 2026-09
Prothena 22.11 11.37 2022-03
PTC Therapeutics 8.76 0 2026-06
Sarepta Therapeutics 32.09 22.66 2026-09
Vanda Pharmaceuticals 16.79 7.07 2023-06
Vertex Pharmaceuticals 29.35 1.3 2026-09